You have the drop on this “Big Money” for the biggest profits in cannabis.

There was a reason Bill Gross was known as “The Bond King.”

Gross co-founded Pacific Investment Management Co. (better known as PIMCO) – and built it into a powerhouse.

At its peak, PIMCO was the biggest bond investor on the planet; the Total Return Fund that Gross ran held more than $290 billion in assets.

I worked for The Bond King.

And I loved it.

As a vice president in charge of growing PIMCO’s inflation-related products, it was my job to get institutions to invest in commodities, inflation-linked bonds (ILBs), a suite of asset allocation strategies, and commercial real estate investments.

Working from an office in sunny Newport Beach, California, I courted pension plans, mutual fund managers, foundations and endowments, and wealth advisors from all around the world.

We referred to these folks as “institutional investors.” But it’s probably more appropriate to refer to them as the “Big Money Crowd.

When I first started working for The Bond King, almost none of the Big Money Crowd was investing in commodities or ILBs. We also took asset allocation to the next level – so that was new – and we also innovated the way the institutional folks invested in real estate.

The bottom line was that we had to convince a lot of really smart people to change the way they saw their business and to innovate and to do something completely new.

And we did it well.

During my 5-year stint, the amount of money the Big Money Crowd invested in our cutting-edge strategies zoomed from about $6 billion to more than $60 billion. By 2006, we basically owned the inflation-related investing space

And that 10-fold move grew the pile of money PIMCO made each year more than any other product, which included Bill’s baby, the aforementioned Total Return Fund.

My time at PIMCO, and the years since, taught me two things.

Both of them critical.

I learned about:

  • The importance of innovation, and how inventiveness can muscle open the pathways to massive new growth.
  • And the massive power of the Big Money Crowd and the catalytic power their investments can have.

Mesh the two – innovation and capital – and you’re looking at the wealth equivalent of the universe-creating “Big Bang” effect.

Meshing is what we’re about to see with cannabis.

And a stock market Big Bang is what I’m predicting; one that’s a starting line for perhaps the greatest wealth journey of your lifetime.

Here today, I’m going to show you exactly how to take this insight and win with it.

Your Chance to Beat Big Money

When I say Big Money, I mean exactly that.

As you read this, more than $21 trillion sits in U.S. mutual funds. Pension plans control even more money. And exchange-traded funds (ETFs) hold another $4 trillion.

It’s a mind-boggling amount of money. But understand this: When these guys identify an investment target, they move in size.

And when that tidal wave of cash comes in, it causes the value of those sector assets to skyrocket.

When innovation spawns new sectors, it’s usually the Big Money that floods in first and ahead of the grassroots money from Main Street investors. That’s how it played out with information technology stocks. That’s what happened with biotech. And that continues to happen with social media.

But cannabis has been different.

And that’s giving regular investors the kind of moneymaking chance that comes along maybe once or twice in a lifetime.

With cannabis, Big Money has up to now been frozen in place on the sidelines. Its indecisiveness has been created by the reality that cannabis remains illegal at the federal level.

But as I hinted here Tuesday, Big Money’s patience has run out.

Just look at the latest moves by Putnam Investments LLC. This Boston-based mutual fund firm controls $182 billion. And it just bought 6 million shares of 4 Front Ventures – a multi-state operator (MSO) – giving Putnam a 5% stake in the company.

Wasatch Advisors Inc., a smaller player with only $18 billion (yes, $18 billion is “small” in the institutional world), now has the second-biggest stake in Cresco Labs Inc. (OTC: CRLBF).

But this next Big-Money Player is gargantuan: With more than $2.4 trillion in assets, Fidelity Investments now owns a stake in Curaleaf Holdings Inc. (OTC: CURLF), which is the biggest cannabis company by revenue on the planet.

And now that the New York Stock Exchange (NYSE) has listed an ETF holding plant-touching cannabis companies based in the United States, the “listing” door has been kicked wide open for other U.S. cannabis companies.

This means major stock index operators – like Standard & Poor’s and FTSE Russell – will soon add those companies to their offerings. And another crucial group of Big Money players (the large pension plans) will have to allocate billions of dollars to cannabis stocks to keep their own investment performances from falling behind.

Pension Funds Turn to Cannabis Stocks to Make Teachers Rich

For proof, just look at who owns another must-own cannabis stock for pension plans.

Innovative Industrial Properties Inc. (NYSE: IIPR), trades on the Big Board. It’s also a part of the Russell 3000, the Russell 2000, and S&P 600 stock indices – to name a few.

As I know from my days with The Bond King, hundreds – heck, even thousands – of mutual funds, ETFs, and pension plans align their investments with these indexes. And because IIPR is part of these indices, these Big Money players have no choice but to own the stock.

Here’s just a few, along with how much money they actually move around:

  • New York State Teachers’ Retirement System – $122 billion.
  • New York State Common Retirement Fund – $207 billion.
  • California State Teachers’ Retirement System – $246 billion

Back during my PIMCO days, I worked the boardrooms of all these players. That was one of the ways I “courted” that institutional money. So I know how it all works. And I’ve seen how, when these guys target a stock, its share price just zooms.

At last count, 17 state pension plans owned a piece of IIPR. And as other big cannabis stocks like Trulieve Cannabis Corp. (OTC: TCNNF), Curaleaf, and Green Thumb Industries (OTC: GTBIF) start trading on the NYSE or Nasdaq, the pension plans and all the other Big Money players will have to own them.

Within this arena, the cannabis story only gets better because most of the players I’ve been talking about so far are what’s known in the business as “passive” investors. They’re passive because they aren’t traders; their investments mirror the holdings of whatever index they are benchmarked against.

To fully understand what lies ahead, there’s a second group of Big Money players, referred to as the “active” crowd, that we need to talk about.

Their influence is just as big. And an exchange listing of a cannabis stock will draw the “active” players in, too.

Let Big Money Reward You for Your Foresight

Active investors see how cannabis stocks can lead to billions in profits. To make that happen, the active players need the ability to trade the millions of shares of stock that a major exchange provides.

This includes pension plans, mutual funds, hedge funds – you name it.

They all see the innovation and growth that cannabis legalization sets up. And, before you know it, they’ll be elbowing each other out of the way in a scramble to claim their billion-dollar stakes.

That hasn’t happened, yet, but we’ll see it, and soon. We’re seeing that meshing of innovation and capital right now. That gives you a bit more of a window to make your move. But not for long.

The Big Bang moment for cannabis is here.

Move now ahead of the Big Money influx, and you’ll reap the windfall of the 10x returns that tidal wave of capital creates. You’ll be the one selling your shares to them at prices five to 10 times more than you paid.

But you have to pick your spots. You can’t just blindly buy a bunch of cannabis stocks and hope to make a fortune. You need insight into which companies stand the best chance at creating wealth for shareholders.

Which management teams are top notch and built to last.

And you can get the drop on everything you need to know to navigate the biggest and best investments at the National Institute for Cannabis Investors (NICI).

You’ll know what to buy, when to buy, and when to sell. If you aren’t a member yet, you are free to access all of the information about the perks of NICI Membership right here.

The path to fortune is never a straight line, but you can secure your spot at the cannabis Big Bang starting line.

Take care,


Don Yocham
Executive Director, National Institute for Cannabis Investors


Comments

14 responses to “For the First Time in Investing History, the Playing Field Is Tilted in Your Favor”

  1. Are you saying that Trulieve Cannabis Corp , Curaleaf, and Green Thumb Industries will soon be on the trading on the NYSE or the NASDAQ and if so when ? cause if the company are on the OTC market my brokerage account won’t accepted it .

  2. Don . I notice you didn’t give the call letters of 4 Front Ventures was this a over site? How do we find out more on them?

  3. Once I learned I couldn’t trade OTC stock through my 401k. I’m not a fan of people telling me what I can’t do with my own money. I settled in well with TD Ameritrade which lets me self trade anything I want. The customer service is 24/7. Even during COVID when up late planning my trades for next day they will answer my questions at 3 am, this is my favorite part. It really doesn’t cost much to invest in OCT stock. $100 here or there will take you a long way. I’ve studied and taught myself. There’s a lot of stock research firms you can learn a lot from. I wish I knew then at start of my 401k what I know now instead of letting it just sit there in boring mutual funds. I f I would’ve understood what I could do with it, I could’ve grown it ridiculously. I was young and didn’t know any better. Also when I did start learning I would’ve went straight to learning options trading instead of the years of just buying and selling individual stocks. You gotta just start.!

Leave a Reply

Your email address will not be published. Required fields are marked *